Selective
Bibliography of Dr.
William Farrar
Laboratory of Cancer
Prevention, NCI
"Prostate Cancer Stem
Cells"
Wednesday,
November 11, 2009
1. Mathews LA, Crea F, Farrar WL
Epigenetic
gene regulation in stem cells and correlation to cancer
DIFFERENTIATION
78 (1):1-17 Jul 2009
2. Klarmann GJ, Hurt EM, Mathews LA, Zhang X,
Duhagon MA, Mistree T, Thomas SB, Farrar WL
Invasive
prostate cancer cells are tumor initiating cells that have a stem cell-like
genomic signature
CLINICAL AND EXPERIMENTAL METASTASIS 26 (5):433-446
2009
3. Kawasaki BT, Hurt EM, Kalathur M, Duhagon MA, Milner JA, Kim
YS, Farrar WL
Effects
of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells:
An integrated molecular profiling approach
PROSTATE 69 (8):827-837 Jun
1 2009
4. Kawasaki BT, Hurt EM, Mistree T, Farrar WL
Targeting
cancer stem cells with phytochemicals
MOLECULAR INTERVENTIONS 8
(4):174-184 Aug 2008
5. Qin HR, Kim HJ, Kim JY, Hurt EM, Klarmann GJ,
Kawasaki BT, Duhagon Serrat MA, Farrar WL
Activation
of signal transducer and activator of transcription 3 through a phosphomimetic
serine 727 promotes prostate tumorigenesis independent of tyrosine 705
phosphorylation
CANCER RESEARCH 68 (19):7736-7741 Oct 1 2008
6. Sharifi N, Hurt EM, Thomas SB, Farrar WL
Effects
of manganese superoxide dismutase silencing on androgen receptor function and
gene regulation: implications for castration-resistant prostate cancer
CLININICALCANCER RESEARCH 14 (19):6073-6080 Oct 1 2008
7. Kawasaki BT,
Farrar WL
Cancer
stem cells, CD200 and immunoevasion
TRENDS IN IMMUNOLOGY 29
(10):464-468 Oct 2008
8. Hurt EM, Farrar WL
Cancer
stem cells: the seeds of metastasis?
MOLECULAR INTERVENTIONS 8
(3):140-142 Jun 2008
9. Sharifi N, Hurt EM, Farrar WL
Androgen
receptor expression in prostate cancer stem cells: is there a
conundrum?
CANCER CHEMOTHERAPY AND PHARMACOLOGY 62 (5):921-923 Oct
2008
10. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL
CD44(+)CD24(-)
prostate cells are early cancer progenitor/stem cells that provide a model for
patients with poor prognosis
BRITISH JOURNAL OF CANCER 98 (4):756-765
Feb 19 2008
Created 10/8/09
